Dexmedetomidine on renal ischemia-reperfusion injury in rats: assessment by means of NGAL and histology

References

• Himmelfarb J, Ikizler TA. Acute kidney injury: Changing lexicography, definitions, and epidemiology. Kidney Int. 2007;71:971–976
   PubMedGoogle Scholar
• Mahon P, Shorten G. Perioperative acute renal failure. Curr Opin Anaesthesiol. 2006;19:332–338
   PubMedGoogle Scholar
• Jiang B, Liu X, Chen H, et al. Ischemic postconditioning attenuates renal ischemic/reperfusion injury in mongrel dogs. Urology. 2010;76:1519.e1511–1517
   Google Scholar
• Bonventre JV, Yang L. Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest. 2011;121:4210–4221
   PubMed Web of Science ®Google Scholar
• Coursin DB, Coursin DB, Maccioli GA. Dexmedetomidine. Curr Opin Crit Care. 2001;7:221–226
   PubMedGoogle Scholar
• Ramsay MA, Luterman DL. Dexmedetomidine as a total intravenous anesthetic agent. Anesthesiology. 2004;101:787–790
   PubMed Web of Science ®Google Scholar
• Sato K, Kimura T, Nishikawa T, Tobe Y, Masaki Y. Neuroprotective effects of a combination of dexmedetomidine and hypothermia after incomplete cerebral ischemia in rats. Acta Anaesthesiol Scand. 2010;54:377–382
   PubMed Web of Science ®Google Scholar
• Hoffman WE, Kochs E, Werner C, Thomas C, Albrecht RF. Dexmedetomidine improves neurologic outcome from incomplete ischemia in the rat. Reversal by the alpha 2-adrenergic antagonist atipamezole. Anesthesiology. 1991;75:328–332
   PubMed Web of Science ®Google Scholar
• Okada H, Kurita T, Mochizuki T, Morita K, Sato S. The cardioprotective effect of dexmedetomidine on global ischemia in isolated rat hearts. Resuscitation. 2007;74:538–545
   PubMed Web of Science ®Google Scholar
• Kocoglu H, Ozturk H, Ozturk H, Yilmaz F, Gulcu N. Effect of dexmedetomidine on ischemia-reperfusion injury in rat kidney: A histopathologic study. Ren Fail. 2009;31:70–74
   PubMed Web of Science ®Google Scholar
• Gu J, Sun P, Zhao H, et al. Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice. Crit Care. 2011;15:R153
   PubMed Web of Science ®Google Scholar
• Curtis FG, Vianna PT, Viero RM, et al. Dexmedetomidine and S(+)-ketamine in ischemia and reperfusion injury in the rat kidney. Acta Cir Bras. 2011;26:202–206
   PubMedGoogle Scholar
• Devarajan P. Review: Neutrophil gelatinase-associated lipocalin: a troponin-like biomarker for human acute kidney injury. Nephrology (Carlton). 2010;15:419–428
   PubMed Web of Science ®Google Scholar
• Merrikhi A, Gheissari A, Mousazadeh H. Urine and serum neutrophil gelatinase-associated lipocalin cut-off point for the prediction of acute kidney injury. Adv Biomed Res. 2014;3:66
   PubMedGoogle Scholar
• Azevedo VL, Santos PS, Oliveira GS, Jr et al. The effect of 6% hydroxyethyl starch vs. Ringer's lactate on acute kidney injury after renal ischemia in rats. Acta Cir Bras. 2013;28:5–9
   PubMedGoogle Scholar
• Modolo NS, Castiglia YM, Ganem EM, Braz JR, Vianna PT, Vane LA. Acute renal ischemia model in dogs: Effects of metoprolol. Ren Fail. 2001;23:1–10
   PubMed Web of Science ®Google Scholar
• Park Y, Hirose R, Dang K, et al. Increased severity of renal ischemia-reperfusion injury with venous clamping compared to arterial clamping in a rat model. Surgery. 2008;143:243–251
   PubMedGoogle Scholar
• Delbridge MS, Shrestha BM, Raftery AT, El Nahas AM, Haylor JL. The effect of body temperature in a rat model of renal ischemia-reperfusion injury. Transplant Proc. 2007;39:2983–2985
   PubMed Web of Science ®Google Scholar
• Zager RA, Altschuld R. Body temperature: An important determinant of severity of ischemic renal injury. Am J Physiol. 1986;251:F87–F93
   PubMedGoogle Scholar
• Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology. 2000;93:382–394
   PubMed Web of Science ®Google Scholar
• Leblanc M, Kellum JA, Gibney RT, Lieberthal W, Tumlin J, Mehta R. Risk factors for acute renal failure: Inherent and modifiable risks. Curr Opin Crit Care. 2005;11:533–536
   PubMed Web of Science ®Google Scholar
• Woodson BW, Wang L, Mandava S, Lee BR. Urinary cystatin C and NGAL as early biomarkers for assessment of renal ischemia-reperfusion injury: A serum marker to replace creatinine? J Endourol. 2013;27:1510–1515
   PubMed Web of Science ®Google Scholar
• Health USDo, Human S, Food, Drug A, Center for Drug E, Research C. Guidance for Industry: Estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers; 2005. Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm078932.pdf. Accessed October, 2013
   Google Scholar
• Fujii T, Takaoka M, Tsuruoka N, Kiso Y, Tanaka T, Matsumura Y. Dietary supplementation of L-carnosine prevents ischemia/reperfusion-induced renal injury in rats. Biol Pharm Bull. 2005;28:361–363
   PubMed Web of Science ®Google Scholar
• Islam CF, Mathie RT, Dinneen MD, Kiely EA, Peters AM, Grace PA. Ischemia-reperfusion injury in the rat kidney: The effect of preconditioning. Br J Urol. 1997;79:842–847
   PubMedGoogle Scholar
• Punuru P, Sujatha D, Kumari BP, Charisma VV. Evaluation of aqueous extract of Murraya koenigii in unilateral renal ischemia reperfusion injury in rats. Indian J Pharmacol. 2014;46:171–175
   PubMedGoogle Scholar
• Sugita S, Okabe T, Sakamoto A. Continuous infusion of dexmedetomidine improves renal ischemia-reperfusion injury in rat kidney. J Nippon Med Sch. 2013;80:131–139
   PubMed Web of Science ®Google Scholar
• Sutton AJ, Duval SJ, Tweedie RL, Abrams KR, Jones DR. Empirical assessment of effect of publication bias on meta-analyses. Br Med J. 2000;320:1574–1577
   PubMed Web of Science ®Google Scholar
• Walker E, Hernandez AV, Kattan MW. Meta-analysis: Its strengths and limitations. Cleve Clin J Med. 2008;75:431–439
   PubMed Web of Science ®Google Scholar